Jian Yang, Deng Chengliang, Wei Zairong
Department of Burns and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi Guizhou, 563003, P. R. China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 Feb 15;37(2):240-246. doi: 10.7507/1002-1892.202210009.
To summarize the research progress of combined surgical treatment of lymphedema based on vascularized lymph node transfer (VLNT), and to provide systematic information for combined surgical treatment of lymphedema.
Literature on VLNT in recent years was extensively reviewed, and the history, treatment mechanism, and clinical application of VLNT were summarized, with emphasis on the research progress of VLNT combined with other surgical methods.
VLNT is a physiological operation to restore lymphatic drainage. Multiple lymph node donor sites have been developed clinically, and two hypotheses have been proposed to explain its mechanism for the treatment of lymphedema. But it has some inadequacies such as slow effect and limb volume reduction rate less than 60%. To address these inadequacies, VLNT combined with other surgical methods for lymphedema has become a trend. VLNT can be used in combination with lymphovenous anastomosis (LVA), liposuction, debulking operation, breast reconstruction, and tissue engineered material, which have been shown to reduce the volume of affected limbs, reduce the incidence of cellulitis, and improve patients' quality of life.
Current evidence shows that VLNT is safe and feasible in combination with LVA, liposuction, debulking operation, breast reconstruction, and tissue engineered material. However, many issues need to be solved, including the sequence of two surgeries, the interval between two surgeries, and the effectiveness compared with surgery alone. Rigorous standardized clinical studies need to be designed to confirm the efficacy of VLNT alone or in combination, and to further discuss the subsistent issues in the use of combination therapy.
总结基于带血管蒂淋巴结转移术(VLNT)的淋巴水肿联合手术治疗的研究进展,为淋巴水肿联合手术治疗提供系统信息。
广泛回顾近年来关于VLNT的文献,总结VLNT的历史、治疗机制及临床应用,重点阐述VLNT联合其他手术方法的研究进展。
VLNT是一种恢复淋巴引流的生理性手术。临床上已开发出多个淋巴结供区,并提出两种假说来解释其治疗淋巴水肿的机制。但它存在起效慢、肢体体积缩小率小于60%等不足。为解决这些不足,VLNT联合其他手术方法治疗淋巴水肿已成为一种趋势。VLNT可与淋巴静脉吻合术(LVA)、抽脂术、减容手术、乳房重建及组织工程材料联合应用,已显示出可减少患肢体积、降低蜂窝织炎发生率并改善患者生活质量。
目前证据表明,VLNT联合LVA、抽脂术、减容手术、乳房重建及组织工程材料是安全可行的。然而,仍有许多问题需要解决,包括两种手术的顺序、两次手术的间隔时间以及与单独手术相比的有效性。需要设计严格规范的临床研究来证实VLNT单独或联合应用的疗效,并进一步探讨联合治疗中存在的问题。